Similar Survival, Less Toxicity With Decitabine vs Chemo in AML Similar Survival, Less Toxicity With Decitabine vs Chemo in AML
For patients with acute myeloid leukemia, treatment with decitabine prior to stem cell transplantation had similar overall survival and much less toxicity compared with intensive chemotherapy.Medscape Medical News
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Hematology-Oncology News Source Type: news
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Chemotherapy | Hematology | Leukemia | Stem Cell Therapy | Stem Cells | Toxicology | Transplant Surgery | Transplants